Verrica Pharmaceuticals (VRCA) Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. EVMN
9. DYN
10. USB

Go back to Verrica Pharmaceuticals (VRCA) Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315
(NASDAQ: VRCA) Delayed: 5.40 +0.14 (2.66%)
Previous Close $5.26    52 Week High $ 
Open $5.25    52 Week Low $ 
Day High $5.40    P/E N/A 
Day Low $5.25    EPS $ 
Volume 6,910